Nanologica Logo

Nanologica

ISIN

SE0005454873

Ticker

NICA

Sector

Health Care

Sub-Industry

Life Sciences Tools & Services

Country

Sweden

Year Founded

2004

About Nanologica

Company Description

Nanologica manufactures, develops, and sells nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size, porosity, and surface properties of silica particles, creating opportunities to develop unique products.

The company’s vision is to contribute to better and cheaper medicine through porous silica. In Chromatography, the aim is to make diabetes drugs and other peptide-based drugs available to more patients by providing products that can lower the production costs at the manufacturers. In Drug Development, the company’s platform for inhalation is developed to give patients with severe lung diseases access to new or improved treatments.

Headcount

20

Served Area

Worldwide

Headquarters

Forskargatan 20 G
15136, Södertälje
Sweden

Insider Trades

Date Trading entity / Person Association Trade type Volume
10.10.2022 Tomas Kramar Other Buy SEK 166,000.00
10.10.2022 Tomas Kramar Other Buy SEK 100,000.00
05.10.2022 Sitbon Bioscience Partner ZENZ AB Other Buy SEK 66,660.00
08.06.2021 Andreas Bhagwani Other Buy SEK 1,348,500.00
08.06.2021 Andreas Bhagwani Other Sell SEK 1,020,000.00
08.06.2021 Andreas Bhagwani Other Other SEK 767,863.80
08.06.2021 Andreas Bhagwani Other Buy SEK 503,652.60
08.06.2021 Tomas Kramar Other Buy SEK 300,000.00
08.06.2021 Investmentaktiebolaget Akkumula Other Buy SEK 150,000.00
07.06.2021 Mattias Bengtsson Other Buy SEK 195,000.00

Capital Markets Information

ISIN

SE0005454873

LEI

54930017L41C7P87LP22

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.